ES2049703T1 - Derivados de acidos biliares sulfurados. - Google Patents

Derivados de acidos biliares sulfurados.

Info

Publication number
ES2049703T1
ES2049703T1 ES93100266T ES93100266T ES2049703T1 ES 2049703 T1 ES2049703 T1 ES 2049703T1 ES 93100266 T ES93100266 T ES 93100266T ES 93100266 T ES93100266 T ES 93100266T ES 2049703 T1 ES2049703 T1 ES 2049703T1
Authority
ES
Spain
Prior art keywords
sulfurated
derivatives
biliar
acids
biliar acids
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES93100266T
Other languages
English (en)
Other versions
ES2049703T3 (es
Inventor
Giangermano Giuliani
Giuliano Frigerio
Roberto Pellicciari
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Giuliani SpA
Original Assignee
Giuliani SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Giuliani SpA filed Critical Giuliani SpA
Publication of ES2049703T1 publication Critical patent/ES2049703T1/es
Application granted granted Critical
Publication of ES2049703T3 publication Critical patent/ES2049703T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J31/00—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring
    • C07J31/003—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring the S atom directly linked to a ring carbon atom of the cyclopenta(a)hydrophenanthrene skeleton
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J31/00—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring
    • C07J31/006—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring not covered by C07J31/003

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

LOS COMPUESTOS DE FORMULA 1: EN DONDE LOS DIVERSOS GRUPOS R TIENEN LOS SIGNIFICADOS DEFINIDOS EN LA PATENTE, SON DE UTILIDAD COMO MEDICAMENTOS PARA EL TRATAMIENTO DE ENFERMEDADES HEPATOBILIARES.
ES93100266T 1992-01-17 1993-01-11 Derivados sulfurados de acidos biliares. Expired - Lifetime ES2049703T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITMI920082A IT1258788B (it) 1992-01-17 1992-01-17 Derivati solforati di acidi biliari

Publications (2)

Publication Number Publication Date
ES2049703T1 true ES2049703T1 (es) 1994-05-01
ES2049703T3 ES2049703T3 (es) 1998-09-16

Family

ID=11361585

Family Applications (1)

Application Number Title Priority Date Filing Date
ES93100266T Expired - Lifetime ES2049703T3 (es) 1992-01-17 1993-01-11 Derivados sulfurados de acidos biliares.

Country Status (10)

Country Link
US (1) US5321019A (es)
EP (1) EP0551844B1 (es)
JP (1) JP3490470B2 (es)
AT (1) ATE167869T1 (es)
CA (1) CA2087298C (es)
DE (2) DE551844T1 (es)
DK (1) DK0551844T3 (es)
ES (1) ES2049703T3 (es)
GR (1) GR930300124T1 (es)
IT (1) IT1258788B (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MY117939A (en) * 1996-07-25 2004-08-30 Lg Chemical Ltd Composition for enhancing oral hygiene
US20060260005A1 (en) * 1998-02-26 2006-11-16 Zhizhen Chen Transformation of Brassica
US20040045056A1 (en) * 1998-02-26 2004-03-04 Zhizheng Chen Transformation of Brassica
US7960439B1 (en) 2006-06-12 2011-06-14 Iowa State University Research Foundation, Inc. Environmentally sensitive foldable oligomers

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU206367B (en) * 1988-04-30 1992-10-28 Sandoz Ag Process for producing acid addition salts of steroid carboxylic acid-amidated taurine and glycine, as well as pharmaceutical compositions comprising such salts
GB8910364D0 (en) * 1989-05-05 1989-06-21 Nat Res Dev Anti-fungal compounds
US5250524A (en) * 1990-12-06 1993-10-05 Hoechst Aktiengesellschaft Bile acid derivatives, process for their preparation and use of these compounds as pharmaceuticals

Also Published As

Publication number Publication date
GR930300124T1 (en) 1993-12-30
JP3490470B2 (ja) 2004-01-26
US5321019A (en) 1994-06-14
HK1012007A1 (en) 1999-07-23
IT1258788B (it) 1996-02-29
CA2087298A1 (en) 1993-07-18
ITMI920082A1 (it) 1993-07-17
ES2049703T3 (es) 1998-09-16
EP0551844B1 (en) 1998-07-01
CA2087298C (en) 2003-09-09
DE69319356T2 (de) 1998-11-12
DK0551844T3 (da) 1999-04-12
EP0551844A3 (es) 1996-05-22
EP0551844A2 (en) 1993-07-21
ITMI920082A0 (it) 1992-01-17
JPH0656880A (ja) 1994-03-01
DE69319356D1 (de) 1998-08-06
ATE167869T1 (de) 1998-07-15
DE551844T1 (de) 1993-11-25

Similar Documents

Publication Publication Date Title
ES2167377T3 (es) Derivados de piridina farmacologicamente activos y procedimientos para la preparacion de los mismos.
FI933770A7 (fi) Farmaseuttisia koostumuksia ihotautien hoitamiseen
ES2170141T3 (es) 4-aminoderivados del acido micofenolico con actividad inmunosupresora.
BG101715A (bg) Тетрациклени спиросъединения,метод за тяхното получаване и приложението им като 5нт долу 1d рецепторни антагонисти
ES2013067A6 (es) Un procedimiento para producir un derivado de piperazina.
AR007828A1 (es) Compuestos derivados de piridilpirrol, procedimiento de preparacion y composiciones farmaceuticas conteniendo los mismos
DE69623899D1 (de) Behandlung von Tinnitus mit neuroprotektiven Wirkstoffen
ES2101858T3 (es) Derivados de geneserina como inhibidores de colinesterasa.
ES2160602T3 (es) Derivados de quinolona y acridinona para el tratamiento de la incontinencia urinaria.
ATE137223T1 (de) Leukotrien-b4-antagonisten
ATE128128T1 (de) Antiatherosclerotische und antithrombotische 2- amino-6-phenyl-4h-pyran-4-one.
UA48958C2 (uk) 9-o-оксимові похідні еритроміцину а та фармацевтична композиція на їх основі
ES2111352T3 (es) Uso de diester fosfato para el tratamiento de enfermedades retinianas.
ES2154311T3 (es) Quinoxalinas, procedimiento para su preparacion y su utilizacion.
AR002272A1 (es) Uso de amidas de fenilciclohexilcarboxilicos
ATE174026T1 (de) Chromen-derivate mit einer trien-kette zur verwendung bei der behandlung der osteoporose und der entzündlichen erkrankungen
BR0309996A (pt) Composto, composição farmacêutica, método de tratar ou melhorar doenças ou condições proliferativas, uso de um composto, e, método de tratar ou melhorar doenças inflamatórias
ES2167721T3 (es) Utilizacion de 1-hidroxi-2-piridonas para el tratamiento de la dermatitis seborreica.
ES2049703T1 (es) Derivados de acidos biliares sulfurados.
ES2156212T3 (es) Derivados de azabicicloheptano n-substituidos como neurolepticos, etc.
ES2185837T3 (es) Utilizacion de derivados de teofilina para el tratamiento y la profilaxis de las enfermedades de choque, nuevos compuestos de xantina y procedimientos para su produccion.
UY26498A1 (es) Pirroles sustituidos
ES2144857T3 (es) Utilizacion de derivados benzonaftalenicos para la fabricacion de medicamentos destinados para el tratamiento de las enfermedades del sistema nervioso.
ES2055440T3 (es) Derivados del acido quinurenico, su preparacion y composiciones farmaceuticas que los contienen.
DE3880304D1 (de) 2-hydroxy-3-aryloxy-propylaminderivate mit kardiovaskulaerer wirkung.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 551844

Country of ref document: ES